Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/214503
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Drzewiecka, Beata | - |
dc.contributor.author | Wessely‐Szponder, Joanna | - |
dc.contributor.author | Świeca, Michał | - |
dc.contributor.author | Espinal, Paula | - |
dc.contributor.author | Fusté i Domínguez, Ester | - |
dc.contributor.author | Fernández‐De La Cruz, Eric | - |
dc.date.accessioned | 2024-07-10T14:41:53Z | - |
dc.date.available | 2024-07-10T14:41:53Z | - |
dc.date.issued | 2024-07-04 | - |
dc.identifier.issn | 2227-9059 | - |
dc.identifier.uri | http://hdl.handle.net/2445/214503 | - |
dc.description.abstract | For centuries, humans have used mushrooms as both food and pro-health supplements. Mushrooms, especially those related to the functions of the human immune system, are rich in dietary fiber, minerals, essential amino acids, and various bioactive compounds and have significant health-promoting properties. Immunoregulatory compounds in mushrooms include lectins, terpenes, terpenoids, polysaccharides, and fungal immunomodulatory proteins (FIPs). The distribution of these compounds varies from one species of mushroom to another, and their immunomodulatory activities depend on the core structures and chemical modifications in the composition of the fractions. In this review, we describe active compounds from medical mushrooms. We summarize potential mechanisms for their in vitro and in vivo activities and detail approaches used in developing and applying bioactive compounds from mushrooms. Finally, we discuss applications of fungal peptides and highlight areas that require improvement before the widespread use of those compounds as therapeutic agents and explore the status of clinical studies on the immunomodulatory activities of mushrooms and their products, as well as the prospect of clinical application of AMPs as ‘drug-like’ compounds with great potential for treatment of non-healing chronic wounds and multiresistant infections. | - |
dc.format.extent | 20 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/biomedicines12071483 | - |
dc.relation.ispartof | Biomedicines, 2024, vol. 12, num.7 | - |
dc.relation.uri | https://doi.org/10.3390/biomedicines12071483 | - |
dc.rights | cc-by (c) Drzewiecka, Beata et al., 2024 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Pèptids | - |
dc.subject.classification | Bolets | - |
dc.subject.classification | Compostos bioactius | - |
dc.subject.other | Peptides | - |
dc.subject.other | Mushrooms | - |
dc.subject.other | Bioactive compounds | - |
dc.title | Bioactive peptides and other immunomodulators of mushroom origin | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 749333 | - |
dc.date.updated | 2024-07-10T14:41:58Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
863127.pdf | 725.94 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License